UniProt ID | A1AG1_HUMAN | |
---|---|---|
UniProt AC | P02763 | |
Protein Name | Alpha-1-acid glycoprotein 1 | |
Gene Name | ORM1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 201 | |
Subcellular Localization | Secreted. | |
Protein Description | Functions as transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction.. | |
Protein Sequence | MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQDQCIYNTTYLNVQRENGTISRYVGGQEHFAHLLILRDTKTYMLAFDVNDEKNWGLSVYADKPETTKEQLGEFYEALDCLRIPKSDVVYTDWKKDKCEPLEKQHEKERKQEEGES | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
19 | Pyrrolidone_carboxylic_acid | LLPLLEAQIPLCANL HHHHHHCCCCCCCCC | 28.58 | - | |
19 | Pyrrolidone_carboxylic_acid | LLPLLEAQIPLCANL HHHHHHCCCCCCCCC | 28.58 | 4711474 | |
19 | Pyrrolidone_carboxylic_acid | LLPLLEAQIPLCANL HHHHHHCCCCCCCCC | 28.58 | 4711474 | |
33 | N-linked_Glycosylation | LVPVPITNATLDQIT CCEEECCCCCHHHHC | 31.48 | 15084671 | |
33 | N-linked_Glycosylation | LVPVPITNATLDQIT CCEEECCCCCHHHHC | 31.48 | 1567356 | |
56 | N-linked_Glycosylation | AFRNEEYNKSVQEIQ HHCCHHHHHHHHHCE | 33.15 | 1567356 | |
56 | N-linked_Glycosylation | AFRNEEYNKSVQEIQ HHCCHHHHHHHHHCE | 33.15 | 16335952 | |
65 | Phosphorylation | SVQEIQATFFYFTPN HHHHCEEEEEEECCC | 9.63 | 25627689 | |
72 | N-linked_Glycosylation | TFFYFTPNKTEDTIF EEEEECCCCCCCEEE | 61.90 | 18638581 | |
72 | N-linked_Glycosylation | TFFYFTPNKTEDTIF EEEEECCCCCCCEEE | 61.90 | 1567356 | |
74 | Phosphorylation | FYFTPNKTEDTIFLR EEECCCCCCCEEEEE | 45.81 | 26657352 | |
77 | Phosphorylation | TPNKTEDTIFLREYQ CCCCCCCEEEEEEEE | 13.85 | 26657352 | |
83 | Phosphorylation | DTIFLREYQTRQDQC CEEEEEEEECCCCEE | 14.57 | 26657352 | |
93 | N-linked_Glycosylation | RQDQCIYNTTYLNVQ CCCEEEEEEEEEEEE | 13.16 | 15084671 | |
93 | N-linked_Glycosylation | RQDQCIYNTTYLNVQ CCCEEEEEEEEEEEE | 13.16 | 15084671 | |
103 | N-linked_Glycosylation | YLNVQRENGTISRYV EEEEEEECCCEEEEE | 55.91 | 18638581 | |
103 | N-linked_Glycosylation | YLNVQRENGTISRYV EEEEEEECCCEEEEE | 55.91 | 1567356 | |
109 | Phosphorylation | ENGTISRYVGGQEHF ECCCEEEEECCHHHE | 9.17 | - | |
109 | Nitration | ENGTISRYVGGQEHF ECCCEEEEECCHHHE | 9.17 | - | |
170 | Glycation | LDCLRIPKSDVVYTD HHHHCCCHHHCEEEC | 57.84 | - | |
170 | Acetylation | LDCLRIPKSDVVYTD HHHHCCCHHHCEEEC | 57.84 | 27178108 | |
175 | Phosphorylation | IPKSDVVYTDWKKDK CCHHHCEEECCCCCC | 9.99 | - | |
179 | Acetylation | DVVYTDWKKDKCEPL HCEEECCCCCCCHHH | 54.63 | 27178108 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of A1AG1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of A1AG1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of A1AG1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
P63_HUMAN | TP63 | physical | 21988832 | |
CCGL_HUMAN | TMEM37 | physical | 21988832 | |
A1AG2_HUMAN | ORM2 | physical | 28514442 | |
PTGDS_HUMAN | PTGDS | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT ASN-33, STRUCTURE OF CARBOHYDRATES, AND MASSSPECTROMETRY. | |
"Enrichment of glycopeptides for glycan structure and attachment siteidentification."; Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.; Nat. Methods 6:809-811(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33 AND ASN-72, STRUCTUREOF CARBOHYDRATES, AND MASS SPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93 AND ASN-103, AND MASSSPECTROMETRY. | |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93AND ASN-103, AND MASS SPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93AND ASN-103, AND MASS SPECTROMETRY. | |
"A proteomic analysis of human bile."; Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.; Mol. Cell. Proteomics 3:715-728(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33 AND ASN-93, AND MASSSPECTROMETRY. | |
"A new strategy for identification of N-glycosylated proteins andunambiguous assignment of their glycosylation sites using HILICenrichment and partial deglycosylation."; Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P.; J. Proteome Res. 3:556-566(2004). Cited for: GLYCOSYLATION AT ASN-33; ASN-72 AND ASN-93, AND MASS SPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-33. | |
"Analysis of the five glycosylation sites of human alpha 1-acidglycoprotein."; Treuheit M.J., Costello C.E., Halsall H.B.; Biochem. J. 283:105-112(1992). Cited for: GLYCOSYLATION AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103. | |
"The disulfide bonds of alpha1-acid glycoprotein."; Schmid K., Buergi W., Collins J.H., Nanno S.; Biochemistry 13:2694-2697(1974). Cited for: DISULFIDE BONDS. | |
Pyrrolidone carboxylic acid | |
Reference | PubMed |
"Structure of alpha 1-acid glycoprotein. The complete amino acidsequence, multiple amino acid substitutions, and homology with theimmunoglobulins."; Schmid K., Kaufmann H., Isemura S., Bauer F., Emura J., Motoyama T.,Ishiguro M., Nanno S.; Biochemistry 12:2711-2724(1973). Cited for: PROTEIN SEQUENCE OF 19-129. |